PTP1B inhibition suggests a therapeutic strategy for Rett syndrome

The X-linked neurological disorder Rett syndrome (RTT) presents with autistic features and is caused primarily by mutations in a transcriptional regulator, methyl CpG–binding protein 2 (MECP2). Current treatment options for RTT are limited to alleviating some neurological symptoms; hence, more effec...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Invest
Main Authors: Krishnan, Navasona, Krishnan, Keerthi, Connors, Christopher R., Choy, Meng S., Page, Rebecca, Peti, Wolfgang, Van Aelst, Linda, Shea, Stephen D., Tonks, Nicholas K.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Clinical Investigation 2015
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4563751/
https://ncbi.nlm.nih.gov/pubmed/26214522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI80323
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares